Related Experiment Videos
Matrix metalloproteinases in multiple sclerosis: is it time for a treatment trial?
Annals of Neurology
|October 17, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tissue inhibitor of matrix metalloproteinases-3 (TIMP-3) lacks involvement in bacterial collagenase-induced intracerebral hemorrhage in mouse.
Acta neurochirurgica. Supplement·2008
Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia.
Cell death and differentiation·2007
Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases.
Apoptosis : an international journal on programmed cell death·2004
Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis.
The European journal of neuroscience·2003
Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.
Annals of neurology·2026
A Human Gait Circuit Derived from Brain Lesions and Deep Brain Stimulation.
Annals of neurology·2026
Trojan mast cells: repurposing allergy for targeted oncolytic delivery.
Trends in pharmacological sciences·2026
Remote photobiomodulation: A systemic approach to neuroprotection.
International review of neurobiology·2026
Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026